Nisha Nanda - Chief Development Officer @ Loxo Oncology

Organization Name	Title At Company	Start Date	End Date
COR	Team member	—	—
ChemGenex Pharmaceuticals	Team Member	—	—
Onyx Pharmaceuticals	Team Member	—	—
Portola Pharmaceuticals	Team Member	—	—
Millennium Pharmaceuticals	Team Member	—	—
The Clinical Development of Carfilzomib	Team Member	—	—

Related Hubs

Hub Name	CB Rank (Hub)
Aisling Capital Portfolio Companies	82,499
Biopharma Acquired Companies	30,940
Therapeutics Acquired Companies With More Than 10 Employees	48,049
Genetics Acquired Companies With More Than $1M in Revenue	102,414
Therapeutics Acquired Companies With More Than $10M in Revenue	88,436
Oncology Acquired Companies	76,281
Acquired Genetics Companies	20,565
Oncology Companies that Exited	39,268
Therapeutics Acquired Companies With Less Than $500M in Revenue	102,161
Biopharma Acquired Companies With More Than $1M in Revenue	36,833